Health Canada Authorised Rapid Test
The COVID-19 antigen rapid test device is a lateral flow in-vitro immunoassay intended to be used for the qualitative detection of the SARS-CoV-2 viral nucleoprotein. This device will detect both viable and nonviable virus in both nasopharyngeal and oropharyngeal secretions.
This test had been authorized for point of care use by Health Canada and is available for immediate dispatch
MediGuard Systems of Canada is an Authorised distributor of the Assuretech Rapid Antigen test.
Support documentation and details available on request
Made in Canada
Health Canada approved
CE Mark and ISO certified
The product has proven to have 100% Specificity and 96% Sensitivety
Stock availabity: 2 Million tests/kit in Canada
Production: up to 5 Million tests/kit weekly
The Rapid Response COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset. This test is authorized for use at the Point of Care i.e., in patient care setting. Results are for the identification of SARS-CoV-2 viral nucleoprotein antigen. Antigen is generally detectable in nasopharyngeal and nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories are required to report all positive results to the appropriate public health authorities. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patientâ??s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The Rapid Responseâ?¢ COVID-19 Antigen Rapid Test Device is for use at the Point of Care for professional use only.
PRODUCT INFORMATION:
Product: Rapid Respose
Sample: Nasal / Nasopharyngeal secretions
Format: Cassette
Quantity: 25 Tests/Kit per box
Time to result: 15 minutes
Storage Condition: 2-30 C/36-86 F
Test Principle: Immunochromatographic Assay
CONTENTS - Individually packed test devices
Extraction Buffer
Extraction tube
Nozzle with filter
Tube stand
Individually packed swabs
Package Insert
58 Rapid Test Kits Suppliers
Short on time? Let Rapid Test Kits sellers contact you.
Rapid Antigen Covid-19Test Kits
200 million boxes - $3 per test
Health Canada, IVD, TUV, CE certification
Product Information:
Quantity: 20 tests/kit
Sample type: Nasopharyngeal swab
Storage temperature: 2-30°C
The most accurate rapid antigen tests worldwide and provide results in 10 minutes.
Test time: 10-15 minutes
Rapid 2019-nCoV IgG/IgM Combo Test is a rapid immunochromatographic assay for the simultaneous detection of IgG and IgM antibodies to 2019 novel coronavirus (2019-nCoV, SARS-CoV-2) in human serum, plasma, or whole blood.
Intended Use:
This product is authorized and intended for use by trained laboratory or healthcare professionals for in vitro diagnostic use. Point-of-care professionals administering tests are required to report all results to the appropriate public health authorities.
Note: Consult your provincial and local health care authorities for POC guidelines for rapid testing use.
Lateral Test and Seal Packers
Logiball 2001L packers are used to test and seal off infiltration in sewer laterals, from the mainline, without any access to cleanouts.
The lateral grouting plug is inverted and deployed into the lateral from the mainline packer assembly. The mainline sleeve then expands to create a minimal grout mixing chamber. The grout is pumped and migrates freely along the restricted expansion of the lateral plug and out through existing pipe defects into the surrounding bedding to seals defects, leaving only a thin layer of grout in the lateral.
The packers are available with different void pressure monitoring systems; a conventional localized liquid filled sensor (S), recommended for acrylamide and acrylate grouts, an in-wall water chamber sensor (W), recommended for stickier grouts such as urethanes and polyurethanes, or both systems (S+W) for a more versatile use. The 2001L Lateral Packer comes standard with two grout ports and a third port dedicated for the test medium (air or water).
2001L Lateral packers work best with a five-hose system. Lateral Grouting Plugs can be interchanged in a matter of minutes to grout distances up to 30 feet if necessary. Lateral Grouting Plugs are available for 4, 5 or 6 diameter laterals. Flexible housing extensions are needed for lateral grouting plugs 24 or longer.
ICGA promotes the proper use of chemical grouting as a safe, economical and effective means to reduce ground water infiltration into sewer collection systems.
The 2001L model is available for 6â?³, 8â?³, 9â?³, 10â?³, 12â?³, 15â?³, 18â?³, 21â?³, 24â?³ and 30â?³ mainlines. For larger diameter contact our sales department. For larger diameters, see our Man Entry Lateral Packers for 36â??â?? & up or contact our sales department.
Features
* As measured on the rubber.
Specifications subject to change without notice.
Logiball Lateral Packer Approximate Void Volumes.
View list of parts for the lateral packers 2001L. (pdf file)
A Control Panel is available to operate the lateral packer from the truck.
Assay+ COVID-19 antigen rapid test is authorized with CE marker, the sensitivity is 90%, the specificity is 98.5%. Assay+ Covid 19 antigen rapid test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein of SARS-CoV-2 from the nasopharyngeal swab from the suspected COVID-19 patients within five days of symptom onset. This test is an aid to differentiate Covid 19 virus infection from other respiratory tract infection caused by coronavirus 229E, NL63, OC43 and HKU1, or severe acute respiratory syndrome caused by SARS-CoV and MERS-CoV. The test should be performed in moderate, high or waived complexity tests. This test can also perform for the Point of Care (POC) purpose.
Assay+ Syphilis ntibody rapid test is manufactured in Canada to detect specific syphilis IgG for the healthcare providers. Assay+ syphilis Rapid Test Kit is qualitative test device for syphilis antibodies from human serum or plasma,. This device has been OEM over one million for our customers.
Sensitivity over 95% syphilis infected patients, and 100% specificity have been proved used by our customers in large quantity.
Assay+ HBV surface antigen rapid test is manufactured in Canada to detect HBV surface antigen for the healthcare providers. Assay+ HBV surface antigen Rapid Test Kit is qualitative test device for HBV antigen in human serum, plasma, whole blood. This device has been used by our end customers with large quantity.
Sensitivity over 95% and 100% specificity have been proved used by our customers in large quantity.
Our COVID-19 rapid test kit can be used effectively on many levels for proper screening and strategic preparedness toward the pandemic. The test kit requires no sophisticated equipment nor laboratory settings. Our SARS-COV-2 Antibody Rapid Test Kit can be applied for screening of COVID-19 disease on the following:
General practitioners and external clinics level to detect previous SARS-COV-2 viral infections on both symptomatic and asymptomatic patients.
Determination of the immunity level of front-line healthcare workers, which can help in the development of pandemic preparedness strategies at national levels.
Epidemiological COVID-19 surveys at national and district levels for research purposes.
Airport screening for arriving /departing passengers to control the pandemic in the aviation industry.
Suspected cases exclusion to minimize cost and time spent in the RT-PCR testing procedures.
Screening on the national level to facilitate decision making regarding lockdown and curfew easing strategies.
Phoenix Bioscience is offering a competitive price for a high-quality kit that is made in Canada and used currently to combat the pandemic in most American cities.
We at Phoenix Bioscience would like to offer you our COVID-19 rapid detection kit based on detecting SARS-COV-2 IgG and IgM and delivers results within 15 minutes.
Made in Canada, CE certified.
Packaging Details: Each package contains 25 individually packed tests, the buffer used in the detection procedure, and disposable pipettes for blood samples collection
Phoenix Bioscience is offering a competitive price for a high-quality kit
